![David M. Hilbert](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David M. Hilbert
No open positions remaining
Profile
David M.
Hilbert was the founder of Arcellx, Inc. (founded in 2014), where he held the titles of President, Chief Executive Officer & Director until 2021.
He was also a former Director & Chief Scientific Officer at Zyngenia, Inc. in 2012, Vice President-Research at Human Genome Sciences, Inc., and Vice President-Research at Cellective Therapeutics, Inc. from 2004 to 2008.
Additionally, he worked as a Principal at the National Cancer Institute.
Dr. Hilbert holds a doctorate from the University of Pennsylvania and an undergraduate degree from Haverford College.
Former positions of David M. Hilbert
| Companies | Position | End |
|---|---|---|
Cellective Therapeutics, Inc.
 Cellective Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Provides biopharmaceutical products | Corporate Officer/Principal | 2008-11-13 |
| ARCELLX, INC. | Chief Executive Officer | 2021-01-21 |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Corporate Officer/Principal | - |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Corporate Officer/Principal | - |
Zyngenia, Inc.
 Zyngenia, Inc. Drugstore ChainsRetail Trade Develops new class of biotherapeutics | Chief Tech/Sci/R&D Officer | - |
Training of David M. Hilbert
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
9
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Health Technology |
Zyngenia, Inc.
Zyngenia, Inc. Drugstore ChainsRetail Trade Develops new class of biotherapeutics | Retail Trade |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Haverford College
 Haverford College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cellective Therapeutics, Inc.
Cellective Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Provides biopharmaceutical products | Health Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
Arcellx, Inc.
 Arcellx, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies | Health Technology |
- Stock Market
- Insiders
- David M. Hilbert
